thieno(2,3-c)isoquinolin-5-one

Names

[ CAS No. ]:
420849-22-5

[ Name ]:
thieno(2,3-c)isoquinolin-5-one

[Synonym ]:
MFCD06407947
TIQ-A
Thieno[2,3-c]isoquinolin-5-one
PARP Inhibitor X,TIQ-A
Thieno[2,3-c]isoquinolin-5(4H)-one
thieno(2,3-c)isoquinolin-5-one

Biological Activity

[Description]:

TIQ-A is a potent TNKS (poly-ART, PARP) inhibitor, with an IC50 of 24 nM for TNKS2. TIQ-A is a potential anti-ischemic agent[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Epigenetics >> PARP

Research Areas >> Cardiovascular Disease

Signaling Pathways >> Cell Cycle/DNA Damage >> PARP

[Target]

TNKS2:24 nM (IC50)

PARP2:210 nM (IC50)

PARP15:230 nM (IC50)

PARP10:>10 μM (IC50)

PARP14:>10 μM (IC50)

[References]

[1]. Maksimainen MM, et al. Analogs of TIQ-A as inhibitors of human mono-ADP-ribosylating PARPs. Bioorg Med Chem. 2021 Dec 15;52:116511.

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
282.2±9.0 °C at 760 mmHg

[ Molecular Formula ]:
C₁₁H₇NOS

[ Molecular Weight ]:
201.244

[ Flash Point ]:
124.5±18.7 °C

[ Exact Mass ]:
201.024841

[ PSA ]:
61.10000

[ LogP ]:
3.16

[ Vapour Pressure ]:
0.0±0.6 mmHg at 25°C

[ Index of Refraction ]:
1.675

[ Storage condition ]:
2-8°C

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H312-H332

[ Precautionary Statements ]:
P280

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
R20/21/22

[ RIDADR ]:
NONH for all modes of transport

Articles

Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5.

J. Immunol. 177(9) , 6489-96, (2006)

We recently used a murine model of allergic airway inflammation to show that poly(ADP-ribose) polymerase-1 (PARP-1) plays an important role in the pathogenesis of asthma-related lung inflammation. In ...

Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: effects on inflammatory markers and lipid content.

J. Pharmacol. Exp. Ther. 329(1) , 150-8, (2009)

We recently showed that poly(ADP-ribose) polymerase (PARP) is activated within atherosclerotic plaques in an animal model of atherosclerosis. Pharmacological inhibition of PARP or reduced expression i...

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.